Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Growth hormone studies in lysinuric protein intolerance

  • 23 Accesses

  • 5 Citations

Abstract

Our two patients with lysinuric protein intolerance, a 14-year-old boy and his 12-year-old sister, showed growth retardation and their bone ages were retarded. Growth hormone secretion responded to glucagon-propranolol and showed a good response to arginine. However, growth hormone showed little response to insulin. After the oral administration of arginine hydrochloride, growth hormone showed a good response to insulin and glucagon-propranolol, and gain in height and weight accelerated. This result may suggest that an adequate supply of arginine is effective in improving the growth retardation in lysinuric protein intolerance.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Awrich AE, Stackhouse WJ, Cantrell JE, Patterson JH, Rudman D (1975) Hyperdibasicaminoaciduria, hyperammonemia, and growth retardation: Treatment with arginine, lysine, and citrulline. J Pediatr 87:731–738

  2. 2.

    Brown JH, Fabre LF Jr, Farrell GL, Adams ED (1972) Hyperlysinuria with hyperammonemia. A new metabolic disorder. Am J Dis Child 124:127–132

  3. 3.

    Chan H, Billmeier GJ Jr, Molinary SV, Tucker HN, Shin B-C, Schaffer A, Cavallo K (1977) Prolonged coma and isoelectric electroencephalogram in a child with lysinuric protein intolerance. J Pediatr 91:79–81

  4. 4.

    Endres W, Zoulek G, Schaub J (1979) Hyperdibasicaminoaciduria in a Turkish infant without evident protein intolerance. Eur J Pediatr 131:33–41

  5. 5.

    Kato T, Tanaka E, Horisawa S (1976) Hyperdibasicaminoaciduria and hyperammonemia in familial protein intolerance. Am J Dis Child 130:1340–1344

  6. 6.

    Kekomäki M, Visakorpi JK, Perheentupa J, Saxén L (1967) Familial protein intolerance with deficient transport of basic amino acids: An analysis of 10 patients. Acta Paediatr Scand 56:617–630

  7. 7.

    Lamberg B-A, Perheentupa J, Rajantie J, Simell O, Saarinen P, Ebeling P, Welin M-G (1981) Increase in thyroxine-binding globulin (TBG) in lysinuric protein intolerance. Acta Endocrinol 97:67–73

  8. 8.

    Malmquist J, Jagenburg R, Lindstedt G (1971) Familial protein intolerance. Possible nature of enzyme defect. N Engl J Med 284:997–1002

  9. 9.

    Perheentupa J, Visakorpi JK (1965) Protein intolerance with deficient transport of basic aminoacids: Another inborn error of metabolism. Lancet 2:813–816

  10. 10.

    Rajantie J, Simell O, Perheentupa J (1980) Basolateral-membrane transport defect for lysine in lysinuric protein intolerance. Lancet 1:1219–1221

  11. 11.

    Rajantie J, Simell O, Perheentupa J (1981) Lysinuric protein intolerance. Basolateral transport defect in renal tubuli. J Clin Invest 67:1078–1082

  12. 12.

    Rajantie J, Simell O, Perheentupa J (1983) Oral administration of urea cycle intermediates in lysinuric protein intolerance: Effect on plasma and urinary arginine and ornithine. Metabolism 32:49–51

  13. 13.

    Rajantie J, Simell O, Perheentupa J (1983) Oral administration of εN-acetyllysine and homocitrulline in lysinuric protein intolerance. J Pediatr 102:388–390

  14. 14.

    Simell O, Perheentupa J, Rapola J, Visakorpi JK, Eskelin L-E (1975) Lysinuric protein intolerance. Am J Med 59:229–240

Download references

Author information

Correspondence to I. Goto.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Goto, I., Yoshimura, T. & Kuroiwa, Y. Growth hormone studies in lysinuric protein intolerance. Eur J Pediatr 141, 240–242 (1984). https://doi.org/10.1007/BF00572769

Download citation

Key words

  • Lysinuric protein intolerance
  • Growth hormone